Kades & Cheifetz’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$427K Buy
17,743
+3,351
+23% +$80.8K 0.22% 72
2024
Q3
$350K Buy
14,392
+151
+1% +$3.63K 0.2% 73
2024
Q2
$339K Buy
14,241
+146
+1% +$3.47K 0.21% 72
2024
Q1
$336K Buy
14,095
+91
+0.6% +$2.17K 0.22% 68
2023
Q4
$335K Buy
14,004
+4,446
+47% +$104K 0.24% 66
2023
Q3
$223K Buy
9,558
+28
+0.3% +$656 0.18% 73
2023
Q2
$224K Hold
9,530
0.17% 74
2023
Q1
$226K Buy
+9,530
New +$224K 0.18% 73

Other funds holding IBDR

Kades & Cheifetz's IBDR Position: Q4 2024 in Review

Kades & Cheifetz increased its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 23% in Q4 2024, buying an estimated $80.8K and bringing the position to 17,743 shares worth $427K. The position accounts for 0.22% of the portfolio, ranked #72.

Kades & Cheifetz first reported a position in IBDR in Q1 2023 and has held it in 8 quarters since. 366 funds tracked by Wall St. Rank hold IBDR as of Q4 2024.

  • Kades & Cheifetz held 17,743 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $427K as of Q4 2024.
  • Kades & Cheifetz bought 3,351 iShares iBonds Dec 2026 Term Corporate ETF shares in Q4 2024, an estimated $80.8K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.22% of Kades & Cheifetz's portfolio in Q4 2024, its #72 holding.
  • Kades & Cheifetz first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2023 and has held it in 8 quarters since.
  • 366 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q4 2024.

Based on Kades & Cheifetz's 13F filing for Q4 2024, filed 13 Jan 2025.